- Home
- TRSG vs RVPH Comparison
TRSG vs RVPH Comparison
Compare TRSG & RVPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- RVPH
- Stock Information
- Founded
- TRSG 1996
- RVPH 2006
- Country
- TRSG Singapore
- RVPH United States
- Employees
- TRSG N/A
- RVPH N/A
- Industry
- TRSG
- RVPH Biotechnology: Pharmaceutical Preparations
- Sector
- TRSG
- RVPH Health Care
- Exchange
- TRSG NYSE
- RVPH Nasdaq
- Market Cap
- TRSG 27.0M
- RVPH 32.8M
- IPO Year
- TRSG 2024
- RVPH N/A
- Fundamental
- Price
- TRSG $1.76
- RVPH $0.39
- Analyst Decision
- TRSG
- RVPH Strong Buy
- Analyst Count
- TRSG 0
- RVPH 5
- Target Price
- TRSG N/A
- RVPH $9.00
- AVG Volume (30 Days)
- TRSG 4.6K
- RVPH 3.7M
- Earning Date
- TRSG 05-14-2025
- RVPH 08-13-2025
- Dividend Yield
- TRSG N/A
- RVPH N/A
- EPS Growth
- TRSG N/A
- RVPH N/A
- EPS
- TRSG N/A
- RVPH N/A
- Revenue
- TRSG $12,810,249.00
- RVPH N/A
- Revenue This Year
- TRSG N/A
- RVPH N/A
- Revenue Next Year
- TRSG N/A
- RVPH N/A
- P/E Ratio
- TRSG N/A
- RVPH N/A
- Revenue Growth
- TRSG N/A
- RVPH N/A
- 52 Week Low
- TRSG $1.00
- RVPH $0.30
- 52 Week High
- TRSG $4.57
- RVPH $4.28
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- RVPH 35.22
- Support Level
- TRSG N/A
- RVPH $0.38
- Resistance Level
- TRSG N/A
- RVPH $0.45
- Average True Range (ATR)
- TRSG 0.00
- RVPH 0.05
- MACD
- TRSG 0.00
- RVPH 0.01
- Stochastic Oscillator
- TRSG 0.00
- RVPH 17.57
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.